Reported value$12.0M289,470 shares at $41.45
For this personNormal for them3 buys · 0 sales on file
Similar buys beat S&P48%419 cases · all buys 46%
Worth a closer look
- Open-market purchase with their own money (Form 4 code P), not a grant or option exercise.
- Their past buys: 4 of 7 beat the S&P 500 over 90 days.
Reasons for caution
- Held indirectly (a trust, fund or family entity), so the economic owner isn't only the named insider.
- Similar past buys beat the S&P 500 only 48% of the time (419 cases); the typical one trailed it by 1.2%.
What happened after this filing
7 days
Pending
due Nov 3
30 days
Pending
due Nov 26
90 days
Pending
due Jan 25
Insider Twins: past buys with the same traits
1 insider buying · no CEO or CFO · $1M+ · stock down 0–20% in 3 months
KXIN Jul 21, 2020 +836.6% vs S&PFSLY Apr 2, 2020 +355.1% vs S&PKOD Aug 21, 2020 +174.0% vs S&PMIST Mar 19, 2020 -98.9% vs S&PBNR Apr 2, 2026 -58.7% vs S&PPAR Jan 7, 2026 -56.9% vs S&PWhat we couldn't check
- Why they traded. Filings don't say, and we don't guess.
- Company news after the filing, and any private terms.
Summary
Srinivas Akkaraju (a director) bought $12M of SRRK at about $41.45 between Oct 23, 2026 and Oct 26, 2026, reported to the SEC on Oct 27, 2026. Buys like this beat the S&P 500 48% of the time since 2020, against 46% for all insider buys. We found 2 points that make it worth a closer look and 2 reasons for caution. History, not a prediction.
Following. We'll keep this page updated; see everything you follow. Want an email when the 30 and 90-day results land? Use the SRRK alerts below.
Written by fixed rules from SEC filings and our measured history, not by an AI model. Public data only. History, not a prediction, and not investment advice.